Development of a convenient in vivo hepatotoxin assay using a transgenic zebrafish line with liver-specific dsred expression

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Zhang, Xiaoyan ^a   Li, Caixia ^a   Gong, Zhiyuan ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ACETYLSALICYLIC ACID; ALCOHOL; AMOXICILLIN; ARSENIC ACID; CHLORPHENIRAMINE; DIMETHYLNITROSAMINE; ESTRADIOL; FATTY ACID; ISONIAZID; LINDANE; MEFENAMIC ACID; PARACETAMOL; PHENYLBUTAZONE; RED FLUORESCENT PROTEIN; DANGEROUS GOODS; PHOTOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FABP10A GENE; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; FLUORESCENCE; IN VIVO STUDY; LIVER LEVEL; LIVER SIZE; LIVER TOXICITY; NONHUMAN; PROCESS DEVELOPMENT; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TOXICITY TESTING; TRANSGENICS; ZEBRA FISH; ANIMAL; BIOSYNTHESIS; DANGEROUS GOODS; DRUG EFFECTS; GENETICS; HUMAN; LIVER; PATHOLOGY; PHARMACOLOGY; TRANSGENIC ANIMAL;

ACETAMINOPHEN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ASPIRIN; HAZARDOUS SUBSTANCES; HUMANS; ISONIAZID; LIVER; LUMINESCENT PROTEINS; PHENYLBUTAZONE; ZEBRAFISH;

EID: 84897983193     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091874     Document Type: Article

References (75)

1. Zimmerman HJ (1993) Hepatotoxicity. Dis Mon 39: 675-787.
2. Zimmerman HJ (1999) Expression of Hepatotoxicity. Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver: 126-131.
3. Hill A, Mesens N, Steemans M, Xu JJ, Aleo MD (2012) Comparisons between in vitro whole cell imaging and in vivo zebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development. Drug Metab Rev 44: 127-140.
4. O'Brien PJ, Irwin W, Diaz D, Howard-Cofield E, Krejsa CM, et al. (2006) High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol 80: 580-604. (Pubitemid 44214526)
5. Tolosa L, Gomez-Lechon MJ, Perez-Cataldo G, Castell JV, Donato MT (2013) HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved. Arch Toxicol 87: 1115-1127.
6. Greenhough S, Hay D (2012) Stem Cell-Based Toxicity Screening. Pharmaceutical Medicine 26: 85-89.
7. Niemela O, Alatalo P (2010) Biomarkers of alcohol consumption and related liver disease. Scand J Clin Lab Invest 70: 305-312.
8. Kasap E, Boyacioglu SO, Korkmaz M, Yuksel ES, Unsal B, et al. (2012) Aurora kinase A (AURKA) and never in mitosis gene A-related kinase 6 (NEK6) genes are upregulated in erosive esophagitis and esophageal adenocarcinoma. Exp Ther Med 4: 33-42.
9. McGrath P, Li CQ (2008) Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today 13: 394-401.
10. McGrath P, Li CQ (2008) Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discovery Today 13: 394-401.
11. Zhang X, Gong Z (2013) Fluorescent Transgenic Zebrafish Tg(nkx2.2a:mEGFP) Provides a Highly Sensitive Monitoring Tool for Neurotoxins. PLoS One 8: e55474.
12. Sukardi H, Chng HT, Chan ECY, Gong ZY, Lam SH (2011) Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models. Expert Opinion on Drug Metabolism & Toxicology 7: 579-589.
13. Korzh S, Pan XF, Garcia-Lecea M, Winata CL, Pan XT, et al. (2008) Requirement of vasculogenesis and blood circulation in late stages of liver growth in zebrafish. Bmc Developmental Biology 8.
14. Das J, Ghosh J, Manna P, Sil PC (2010) Acetaminophen induced acute liver failure via oxidative stress and JNK activation: protective role of taurine by the suppression of cytochrome P450 2E1. Free Radic Res 44: 340-355.
15. Tolman KG (1998) Hepatotoxicity of non-narcotic analgesics. Am J Med 105: 13S-19S.
16. Bhadauria S, Singh G, Sinha N, Srivastava S (2007) Isoniazid induces oxidative stress, mitochondrial dysfunction and apoptosis in Hep G2 cells. Cell Mol Biol (Noisy-le-grand) 53: 102-114. (Pubitemid 46799697)
17. Bhadauria S, Mishra R, Kanchan R, Tripathi C, Srivastava A, et al. (2010) Isoniazid-induced apoptosis in HepG2 cells: generation of oxidative stress and Bcl-2 down-regulation. Toxicol Mech Methods 20: 242-251.
18. Tafazoli S, Spehar DD, O'Brien PJ (2005) Oxidative stress mediated idiosyncratic drug toxicity. Drug Metab Rev 37: 311-325. (Pubitemid 40677507)
19. Nagel R (2002) DarT: The embryo test with the Zebrafish Danio rerio - a general model in ecotoxicology and toxicology. ALTEX 19 Suppl 1: 38-48.
20. Huang X, Zhou L, Gong Z (2012) Liver tumor models in transgenic zebrafish: an alternative in vivo approach to study hepatocarcinogenes. Future Oncol 8: 21-28.
21. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622.
22. Zhang M, Uhanova J, Corbin I, Bernstein C, Minuk GY (2003) Effects of daily, light and moderate-heavy ethanol exposure on extent of hepatic injury and recovery following toxin-induced acute hepatitis in rats. Dig Dis Sci 48: 926-931. (Pubitemid 36470214)
23. Radosavljevic T, Mladenovic D, Jakovljevic V, Vucvic D, Rasc-Markovic A, et al. (2009) Oxidative stress in liver and red blood cells in acute lindane toxicity in rats. Hum Exp Toxicol 28: 747-757.
24. Zucchini-Pascal N, de Sousa G, Pizzol J, Rahmani R (2011) Molecular investigation of the effects of lindane in rat hepatocytes: microarray and mechanistic studies. Food Chem Toxicol 49: 3128-3135.
25. Nadanaciva S, Aleo MD, Strock CJ, Stedman DB, Wang H, et al. (2013) Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes. Toxicol Appl Pharmacol 272: 272-280.
26. Somchit N, Sanat F, Gan EH, Shahrin IA, Zuraini A (2004) Liver injury induced by the non-steroidal anti-inflammatory drug mefenamic acid. Singapore Med J 45: 530-532. (Pubitemid 39564032)
27. Patlolla AK, Todorov TI, Tchounwou PB, van der Voet G, Centeno JA (2012) Arsenic-induced biochemical and genotoxic effects and distribution in tissues of Sprague-Dawley rats. Microchem J 105: 101-107.
28. Singh AP, Goel RK, Kaur T (2011) Mechanisms pertaining to arsenic toxicity. Toxicol Int 18: 87-93.
29. Okada M, Makino A, Nakajima M, Okuyama S, Furukawa S, et al. (2010) Estrogen Stimulates Proliferation and Differentiation of Neural Stem/Progenitor Cells through Different Signal Transduction Pathways. Int J Mol Sci 11: 4114-4123.
30. Storch J, Veerkamp JH, Hsu KT (2002) Similar mechanisms of fatty acid transfer from human anal rodent fatty acid-binding proteins to membranes: liver, intestine, heart muscle, and adipose tissue FABPs. Mol Cell Biochem 239: 25-33. (Pubitemid 35385792)
31. Ung CY, Lam SH, Zhang X, Li H, Ma J, et al. (2011) Existence of inverted profile in chemically responsive molecular pathways in the zebrafish liver. PLoS One 6: e27819.
32. North TE, Babu IR, Vedder LM, Lord AM, Wishnok JS, et al. (2010) PGE2-regulated wnt signaling and N-acetylcysteine are synergistically hepatoprotective in zebrafish acetaminophen injury. Proc Natl Acad Sci U S A 107: 17315-17320.
33. Minigh J (2008) Chlorpheniramine. In: Editors-in-Chief: SJE, David BB, editors. xPharm: The Comprehensive Pharmacology Reference. New York: Elsevier. 1-6.
34. Zimmerman HJ (2000) Drug-induced liver disease. Clinics in Liver Disease 4: 73-96.
35. Katz JA (2005) Chapter 16 - NSAIDs and COX-2-Selective Inhibitors. In: Honorio TB, Md, Srinivasa NR, Robert EM, Spencer SL et al., editors. Essentials of Pain Medicine and Regional Anesthesia (Second Edition). Philadelphia: Churchill Livingstone. 141-158.
36. Hussaini SH, Farrington EA (2007) Idiosyncratic drug-induced liver injury: an overview. Expert Opinion on Drug Safety 6: 673-684. (Pubitemid 351308279)
37. Aithal GP (2011) Hepatotoxicity related to antirheumatic drugs. Nature reviews Rheumatology 7: 139-150.
38. Agúndez JA, Lucena MI, Martínez C, Andrade RJ, Blanca M, et al. (2011) Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 7: 817-828.
39. Aronson JK (2008) Phenylbutazone. In: Aronson JK, editor. Meyler's side effects of analgesics and anti-inflammatory drugs. Boston, MA: Elsevier.
40. Soma LR, Uboh CE, Maylin GM (2012) The use of phenylbutazone in the horse. Journal of Veterinary Pharmacology and Therapeutics 35: 1-12.
41. Lewis JH (2007) Nonsteroidal anti-inflammatory drugs and leukotriene receptor antagonists: pathology and clinical presentation of hepatotoxicity. In: Kaplowitz N, DeLeve LD, editors. Drug-induced liver disease. 2nd ed. New York: Informa Healthcare. 440-464.
42. Somchit N, Sanat F, Gan EH, Shahrin IA, Zuraini A (2004) Liver injury induced by the non-steroidal anti-inflammatory drug mefenamic acid. Singapore medical journal 45: 530-532. (Pubitemid 39564032)
43. Cheng TJ, Chuu JJ, Chang CY, Tsai WC, Chen KJ, et al. (2011) Atherosclerosis induced by arsenic in drinking water in rats through altering lipid metabolism. Toxicol Appl Pharmacol 256: 146-153.
44. Carlson P, Van Beneden RJ (2013) Arsenic exposure alters expression of cell cycle and lipid metabolism genes in the liver of adult zebrafish (Danio rerio). Aquat Toxicol.
45. Wauson EM, Langan AS, Vorce RL (2002) Sodium arsenite inhibits and reverses expression of adipogenic and fat cell-specific genes during in vitro adipogenesis. Toxicological sciences : an official journal of the Society of Toxicology 65: 211-219.
46. Carlson P, Smalley DM, Van Beneden RJ (2013) Proteomic analysis of arsenic-exposed zebrafish (Danio rerio) identifies altered expression in proteins involved in fibrosis and lipid uptake in a gender-specific manner. Toxicol Sci 134: 83-91.
47. Mrema EJ, Rubino FM, Brambilla G, Moretto A, Tsatsakis AM, et al. (2013) Persistent organochlorinated pesticides and mechanisms of their toxicity. Toxicology 307: 74-88.
48. Nolan K, Kamrath J, Levitt J (2012) Lindane toxicity: a comprehensive review of the medical literature. Pediatric dermatology 29: 141-146.
49. Radosavljevic T, Mladenovic D, Jakovljevic V, Vucvic D, Rasc-Markovic A, et al. (2009) Oxidative stress in liver and red blood cells in acute lindane toxicity in rats. Human & experimental toxicology 28: 747-757.
50. Boll M, Weber L, Stampfl A (1995) The effect of gamma- hexachlorocyclohexane (lindane) on the activities of liver lipogenic enzymes and on serum lipids in rats. Zeitschrift für Naturforschung C, Journal of biosciences 50: 135.
51. Vijaya Padma V, Sowmya P, Arun Felix T, Baskaran R, Poornima P (2011) Protective effect of gallic acid against lindane induced toxicity in experimental rats. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 49: 991-998.
52. Zhang H, Liu Y, Wang L, Li Z, Wu J, et al. (2013) Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. Journal of lipid research 54: 345-357.
53. Hewitt KN, Pratis K, Jones ME, Simpson ER (2004) Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 145: 1842-1848. (Pubitemid 38402393)
54. Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly YM, et al. (2000) Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochemical and biophysical research communications 278: 640-645.
55. Knerr S, Schrenk D (2006) Carcinogenicity of 2,3,7,8-tetrachlorodibenzo- p-dioxin in experimental models. Mol Nutr Food Res 50: 897-907. (Pubitemid 44621795)
56. Weber LW, Lebofsky M, Stahl BU, Smith S, Rozman KK (1995) Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8-tetrachlo- rodibenzo-p-dioxin-treated male C57BL/6J and DBA/2J mice. Toxicol Appl Pharmacol 131: 155-162.
57. Cummings AM, Metcalf JL, Birnbaum L (1996) Promotion of endometriosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice: time-dose dependence and species comparison. Toxicol Appl Pharmacol 138: 131-139. (Pubitemid 26159603)
58. Matsumura F, Enan E, Dunlap DY, Pinkerton KE, Peake J (1997) Altered in vivo toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C-SRC deficient mice. Biochem Pharmacol 53: 1397-1404. (Pubitemid 27356110)
59. Richardson SD, Plewa MJ, Wagner ED, Schoeny R, Demarini DM (2007) Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in drinking water: a review and roadmap for research. Mutat Res 636: 178-242. (Pubitemid 350130339)
60. Mizgireuv IV, Majorova IG, Gorodinskaya VM, Khudoley VV, Revskoy SY (2004) Carcinogenic effect of N-nitrosodimethylamine on diploid and triploid zebrafish (Danio rerio). Toxicologic pathology 32: 514-518. (Pubitemid 39258456)
61. Tomatis L, Magee PN, Shubik P (1964) Induction of Liver Tumors in the Syrian Golden Hamster by Feeding Dimethylnitrosamine. J Natl Cancer Inst 33: 341-345.
62. Liteplo RG, Meek ME (2001) N-nitrosodimethylamine: hazard characterization and exposure-response analysis. Journal of Environmental Science and Health, Part C 19: 281-304. (Pubitemid 32538385)
63. Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W (2013) Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 28: 254-273.
64. Bioulac-Sage P, Laumonier H, Laurent C, Zucman-Rossi J, Balabaud C (2008) Hepatocellular adenoma: what is new in 2008. Hepatol Int 2: 316-321.
65. Lam SH, Gong ZY (2006) Modeling liver cancer using zebrafish - A comparative oncogenomics approach. Cell Cycle 5: 573-577.
66. Lam SH, Wu YL, Vega VB, Miller LD, Spitsbergen J, et al. (2006) Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nature Biotechnology 24: 73-75. (Pubitemid 43083168)
67. Le Roch KG, Johnson JR, Florens L, Zhou Y, Santrosyan A, et al. (2004) Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome research 14: 2308-2318. (Pubitemid 39517338)
68. Jayapal KP, Philp RJ, Kok YJ, Yap MG, Sherman DH, et al. (2008) Uncovering genes with divergent mRNA-protein dynamics in Streptomyces coelicolor. PloS one 3: e2097.
69. Maier T, Guell M, Serrano L (2009) Correlation of mRNA and protein in complex biological samples. FEBS letters 583: 3966-3973.
70. Weger BD, Weger M, Jung N, Lederer C, Bräse S, et al. (2013) A Chemical Screening Procedure for Glucocorticoid Signaling with a Zebrafish Larva Luciferase Reporter System. e50439.
71. Kanungo J, Lantz S, Paule MG (2011) In vivo imaging and quantitative analysis of changes in axon length using transgenic zebrafish embryos. Neurotoxicology and teratology 33: 618-623.
72. Kanungo J, Lantz S, Paule MG (2011) In vivo imaging and quantitative analysis of changes in axon length using transgenic zebrafish embryos. Neurotoxicol Teratol 33: 618-623.
73. Kola I, Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nature Reviews Drug Discovery 3: 711-715. (Pubitemid 39173511)
74. Astashkina A, Mann B, Grainger DW (2012) A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacology & therapeutics 134: 82-106.
75. Roth RA, Ganey PE (2011) Animal models of idiosyncratic drug-induced liver injury-Current status. Critical Reviews in Toxicology 41: 723-739.